Prevalence of and Risk Factors for Type 2 Diabetes Mellitus in Hyperlipidemia in China

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2015 Aug 23

PMID 26297334

Citations 29

Authors

Guang-Yu Chen

Lui Li

Fei Dai

Xing-Jian Li

Xiao-Xin Xu

Jian-Gao Fan

Affiliations

Soon will be listed here.

Abstract

Background: We explored the prevalence of and risk factors for type 2 diabetes in the adult population of Shanghai (China) with and without dyslipidemia.

Material And Methods: We conducted a cross-sectional survey including 14 385 adults (aged 16 to 88 years) in Shanghai using a stratified, multistage cluster sampling approach.

Results: Type 2 diabetes and hyperlipidemia were found in 1456 (10.1%) and 4583 (31.9%) subjects, respectively. Type 2 diabetes was more common in males (11.4%) than in females (9.2%, P<0.01), in the elderly (> or =65 years, 22.5%) than in younger (<55 years, <10%, P<0.01) individuals, and in urban (12.8%) than in rural populations (5.2%, P<0.01). Diabetes incidence was higher among patients with hyperlipidemia than in controls (16.9% vs. 7.0%, P<0.01; OR=2.72, 95% CI 2.44-3.03). Compared with controls, the risk for diabetes in subjects with isolated hypertriglyceridemia, isolated hypercholesterolemia, and mixed hyperlipidemia increased 1.75-fold (95% CI 1.53-1.99), 1.53-fold (95% CI 1.17-2.01), and 2.93-fold (95% CI 2.37-3.63), respectively. The fasting plasma glucose (FPG) and 2h-postprandial plasma glucose (2h-PG) increased with age in both sexes. The age- and sex-adjusted FPG and 2h-PG levels in hyperlipidemia were significantly higher than in controls (P<0.01).

Conclusions: A high prevalence of type 2 diabetes in hyperlipidemia patients exists in Shanghai. Hyperlipidemia is associated with elevated blood glucose levels and therefore requires prompt intervention for prevention and treatment of diabetes in patients with dyslipidemia.

Citing Articles

Study of pattern of lipid profile amongst type II diabetic patients of two major tribal populations of Tripura.

Debbarma S, Dasgupta A, Ghosh A, Choudhury K, Kole P, Paul S J Family Med Prim Care. 2025; 13(12):5476-5483.

PMID: 39790778 PMC: 11709035. DOI: 10.4103/jfmpc.jfmpc_1625_23.

Increased prevalence of diabetes mellitus and its metabolic risk factors from 2002 to 2017 in Shanghai, China.

Yang Q, Tian J, Li Y, Yan Q, Xu W, Fu C J Diabetes. 2024; 16(10):e70003.

PMID: 39373346 PMC: 11457206. DOI: 10.1111/1753-0407.70003.

Patterns of Lipid Abnormalities in Obesity: A Comparative Analysis in Normoglycemic and Prediabetic Obese Individuals.

Alshuweishi Y, Almufarrih A, Abudawood A, Alfayez D, Alkhowaiter A, AlSudais H J Pers Med. 2024; 14(9).

PMID: 39338234 PMC: 11432951. DOI: 10.3390/jpm14090980.

Phytochemical components analysis and hypolipidemic effect on hyperlipidemia mice of the aerial parts from .

Hu B, Hu H, Peng D, Wei Z, Wang Q, Kuang H Front Nutr. 2024; 11:1422857.

PMID: 39119464 PMC: 11306067. DOI: 10.3389/fnut.2024.1422857.

A study on the use of acupoint catgut embedding in the treatment of pre-diabetes: a meta-analysis and data mining approach.

Yu Y, Xu X, Tan D, Yin Y, Yang X, Yu R Front Public Health. 2023; 11:1282720.

PMID: 38131018 PMC: 10733528. DOI: 10.3389/fpubh.2023.1282720.

References

Pannacciulli N, De Pergola G, Ciccone M, Rizzon P, Giorgino F, Giorgino R . Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal-weight, overweight, and obese glucose-tolerant young adults. Diabetes Care. 2003; 26(4):1230-4. DOI: 10.2337/diacare.26.4.1230. View

Zhang L, Qiao Q, Tuomilehto J, Hammar N, Janus E, Soderberg S . Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: the DECODA study. Diabetes Metab Res Rev. 2009; 25(6):549-57. DOI: 10.1002/dmrr.994. View

Jia W, Pang C, Chen L, Bao Y, Lu J, Lu H . Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia. 2006; 50(2):286-92. DOI: 10.1007/s00125-006-0503-1. View

Cui H, Wang S, Wang D, Cui C, Chen X, Chen X . Modified classic risk factors for coronary artery disease in Chinese Han population. Chin Med Sci J. 2008; 22(4):216-23. View

Norris S, Kansagara D, Bougatsos C, Fu R . Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2008; 148(11):855-68. DOI: 10.7326/0003-4819-148-11-200806030-00008. View

Zhang L, Qiao Q, Tuomilehto J, Hammar N, Alberti K, Eliasson M . Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE Study. Diabetes Res Clin Pract. 2008; 82(3):364-77. DOI: 10.1016/j.diabres.2008.08.022. View

Ning F, Pang Z, Dong Y, Gao W, Nan H, Wang S . Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China. Diabet Med. 2009; 26(9):855-63. DOI: 10.1111/j.1464-5491.2009.02791.x. View

Ma R, Lin X, Jia W . Causes of type 2 diabetes in China. Lancet Diabetes Endocrinol. 2014; 2(12):980-91. DOI: 10.1016/S2213-8587(14)70145-7. View

Lin K, Chang C . Screening for type 2 diabetes mellitus in adults. Am Fam Physician. 2009; 80(10):1141. View

10.

Wang S, Sun Z, Ruan X, Guo Y, Wang Y, Jin H . Dyslipidaemia among diabetic patients with ischemic stroke in a Chinese hospital. Chin Med J (Engl). 2009; 122(21):2567-72. View

11.

Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J . Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362(12):1090-101. DOI: 10.1056/NEJMoa0908292. View

12.

Wu J, Duan X, Li L, Dai F, Li Y, Li X . Dyslipidemia in Shanghai, China. Prev Med. 2010; 51(5):412-5. DOI: 10.1016/j.ypmed.2010.08.013. View

13.

Xu H, Song Y, You N, Zhang Z, Greenland S, Ford E . Prevalence and clustering of metabolic risk factors for type 2 diabetes among Chinese adults in Shanghai, China. BMC Public Health. 2010; 10:683. PMC: 2989965. DOI: 10.1186/1471-2458-10-683. View

14.

Boden G . Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011; 18(2):139-43. PMC: 3169796. DOI: 10.1097/MED.0b013e3283444b09. View

15.

Chen H, Yu M, Li M, Zhao R, Zhu Q, Zhou W . Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease. Mol Cell Biochem. 2011; 363(1-2):85-91. DOI: 10.1007/s11010-011-1160-3. View

16.

Tavares A, Bocchi E, Guimaraes G . Endothelial function in pre-pubertal children at risk of developing cardiomyopathy: a new frontier. Clinics (Sao Paulo). 2012; 67(3):273-8. PMC: 3297038. DOI: 10.6061/clinics/2012(03)12. View

17.

Taylor F, Huffman M, Macedo A, Moore T, Burke M, Davey Smith G . Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013; (1):CD004816. PMC: 6481400. DOI: 10.1002/14651858.CD004816.pub5. View

18.

Aslan I, Kucuksayan E, Aslan M . Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients. Lipids Health Dis. 2013; 12:54. PMC: 3653690. DOI: 10.1186/1476-511X-12-54. View

19.

. Standards of medical care in diabetes--2014. Diabetes Care. 2013; 37 Suppl 1:S14-80. DOI: 10.2337/dc14-S014. View

20.

Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L . WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med. 2004; 21(4):383-7. DOI: 10.1111/j.1464-5491.2004.01115.x. View